AcelRx Pharmaceuticals, Inc. (ACRX) financial statements (2021 and earlier)

Company profile

Business Address 351 GALVESTON DRIVE
REDWOOD CITY, CA 94063
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments4366106608011375
Cash and cash equivalents271588538010860
Short-term investments1651188 615
Receivables110263 
Inventory, net of allowances, customer advances and progress billings231120 
Inventory231120 
Other undisclosed current assets2210121
Total current assets:4772108638911976
Noncurrent Assets
Operating lease, right-of-use asset34
Nontrade receivables 00    
Property, plant and equipment1615111111910
Restricted cash and investments  00000
Other noncurrent assets1110   
Deferred tax assets, net 1   
Other undisclosed noncurrent assets    000
Total noncurrent assets:1920131211910
TOTAL ASSETS:66911217610012886
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8775666
Accounts payable3221222
Accrued liabilities5654544
Deferred revenue00
Debt9698357
Deferred revenue and credits0031
Other undisclosed current liabilities101110 
Total current liabilities:18141614101314
Noncurrent Liabilities
Long-term debt and lease obligation1624311191618
Long-term debt, excluding current maturities1321311191618
Operating lease, liability34
Liabilities, other than long-term debt0404412
Deferred revenue and credits4412
Deferred revenue 3
Deferred rent credit  0
Other liabilities00     
Other undisclosed noncurrent liabilities8891978373656
Total noncurrent liabilities:10411910098958226
Total liabilities:1221331161121059540
Stockholders' equity
Stockholders' equity attributable to parent, including:(56)(41)4(37)(5)3347
Common stock0000000
Additional paid in capital383357349261241236225
Accumulated other comprehensive income (loss)    0(0)(0)
Accumulated deficit(438)(398)(345)(298)(246)(203)(179)
Warrants and rights outstanding      6
Other undisclosed stockholders' equity attributable to parent      (6)
Total stockholders' equity:(56)(41)4(37)(5)3347
TOTAL LIABILITIES AND EQUITY:66911217610012886

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues522817195
Revenue, net1114 
Sublease income11
Cost of revenue
(Cost of Goods and Services Sold)
(6)(7)(4)(0)(12)(2) 
Gross profit:(1)(5)(2)85175
Operating expenses(40)(50)(38)(47)(49)(39)(43)
Other undisclosed operating income  40122 
Operating loss:(41)(54)(36)(39)(32)(20)(38)
Nonoperating income (expense)11(11)(14)(11)(4)7
Investment income, nonoperating121112 
Interest and debt expense(3)(3)(2)(3)(3)(3)(3)
Other undisclosed income from continuing operations before equity method investments, income taxes    33 
Loss from continuing operations before equity method investments, income taxes:(44)(56)(49)(56)(43)(24)(33)
Other undisclosed income (loss) from continuing operations before income taxes3323  (4)
Loss from continuing operations before income taxes:(40)(53)(47)(52)(43)(24)(38)
Income tax expense (benefit)(0)(0)(0)10(1) 
Net loss:(40)(53)(47)(52)(43)(24)(38)
Other undisclosed net income attributable to parent      4
Net loss available to common stockholders, basic:(40)(53)(47)(52)(43)(24)(33)
Other undisclosed net loss available to common stockholders, diluted     (2)(7)
Net loss available to common stockholders, diluted:(40)(53)(47)(52)(43)(27)(40)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(40)(53)(47)(52)(43)(24)(38)
Comprehensive loss:(40)(53)(47)(52)(43)(24)(38)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent   (0)004
Comprehensive loss, net of tax, attributable to parent:(40)(53)(47)(52)(43)(24)(33)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: